AVP and ischemic stroke: With respect to acutely ischemic stroke patients, De Marchis et al. [27] suggest that copeptin has an important prognostic value, as the aforementioned blood biomarker appears to serve as an independent predictor of both unfavorable functional outcome and mortality at three months following stroke, as well as reliably forecast the development of in-hospital complications.